Significant publications on infectious diseases pharmacotherapy in 2009

Palmer, Hannah R.; Cottreau, Jessica M.; Garey, Kevin W.; Hirsch, Elizabeth B.; Musick, William L.; Tam, Vincent H.; Yeh, Rosa F.
August 2010
American Journal of Health-System Pharmacy;8/1/2010, Vol. 67 Issue 15, pe34
Academic Journal
Purpose. Significant publications on infectious diseases (ID) pharmacotherapy in 2009 are summarized. Summary. On December 31, 2009, the Houston Infectious Diseases Network amassed a list of articles identified as having a significant impact on ID pharmacotherapy. Articles selected were published between January 1, 2009, and December 31, 2009, in prominent, peer-reviewed journals. Articles were selected based on their perceived potential impact on pharmacy practice in ID, human immunodeficiency virus (HIV), or acquired immune deficiency syndrome (AIDS). A list of 45 articles not related to HIV infection and 17 articles related to HIV infection was distributed to members of the Society of Infectious Diseases Pharmacists (SIDP) via an Internet survey. Members were asked to select the 10 publications (from the list of 45 non-HIV-related articles) that they felt contributed most to ID pharmacotherapy and to select the single most significant publication from the list of 17 articles related to HIV or AIDS. Of the 531 SIDP members surveyed, 100 responded (18.8%). The top 10 articles (9 non-HIV-related and 1 HIVrelated) identified from this survey are summarized in this article. Three of the top 10 articles selected from the non-HIV category included new or updated ID guidelines. Summaries of the top articles selected (9 non-HIV-related and 1 HIV-related) from this survey are included. Conclusion. Due to the growing number of articles published each year, it is difficult to maintain a current knowledge of significant publications in ID. This review of significant publications in ID pharmacotherapy can be helpful by lessening this burden.


Related Articles

  • HIV chemotherapy. Richman, Douglas D. // Nature;4/19/2001, Vol. 410 Issue 6831, p995 

    The use of chemotherapy to suppress replication of the human immunodeficiency virus (HIV) has transformed the face of AIDS in the developed world. Pronounced reductions in illness and death have been achieved and healthcare utilization has diminished. HIV therapy has also provided many new...

  • ANTI-HIV POTENTIAL OF MEDICINALLY IMPORTANT PLANTS. KAUR, RAJANDEEP; KHARB, RAJEEV // International Journal of Pharma & Bio Sciences;Jul-Sep2011, Vol. 2 Issue 3, pP.387 

    The acquired immunodeficiency syndrome (AIDS) is a result of human immunodeficiency virus (HIV) infection which leads to severe suppression of immune functions. AIDS is a real threat to the health of mankind, and the search for effective therapies is still of great importance. However besides...

  • New hope for eradication of HIV from the body: the role of polymeric nanomedicines in HIV/AIDS pharmacotherapy. Lenjisa, Jimma Likisa; Alebachew Woldu, Minyahil; Satessa, Gizaw Dabessa // Journal of Nanobiotechnology;2014, Vol. 12 Issue 1, p1 

    Human immunodeficiency virus continued to be the greatest challenge and killer disease of the 21st century despite the advent of potent highly active antiretroviral therapy which are limited by their severe adverse effects, significant drug interactions, frequent dosing, limited bioavailability,...

  • Sex-Based Differences in Saquinavir Pharmacology and Virologic Response in AIDS Clinical Trials Group Study 359. Fletcher, Courtney V.; Jiang, Hongyu; Brundage, Richard C.; Acosta, Edward P.; Haubrich, Richard; Katzenstein, David; Gulick, Roy M. // Journal of Infectious Diseases;4/1/2004, Vol. 189 Issue 7, p1176 

    AIDS Clinical Trials Group study 359 was a controlled study of saquinavir with either ritonavir or nelfinavir, together with delavirdine, adefovir, or both, in indinavir-experienced persons. Saquinavir was common in all study arms, and the study investigated relationships among characteristics...

  • Carboplatin/methylprednisolone/vinorelbine.  // Reactions Weekly;3/28/2009, Issue 1245, p10 

    The article describes the case of a 58-year-old man with human immunodeficiency virus (HIV) infection who developed Trichoderma fungaemia after receiving chemotherapy for bronchopulmonary adenocarcinoma. Particular focus is given to his medical history and dosing regimen. He experienced...

  • Highly active antiretroviral therapy in a large urban clinic: Risk factors for viologic failure... Lucas, Gregory M.; Chaisson, Richard E. // Annals of Internal Medicine;07/20/99, Vol. 131 Issue 2, p81 

    Studies factors associated with failure to suppress HIV-1 RNA levels and adverse drug reactions in patients on protease inhibitor-containing therapy in Baltimore, Maryland. Levels of HIV-1 RNA; Effects of high rates of missed clinic appointments, ethnicity, age, injection drug use, CD4...

  • Risk network structure in the early epidemic phase of HIV transmission in Colorado Springs. J J Potterat // Sexually Transmitted Infections;Apr2002, Vol. 78 Issue 0, pi159 

    This study describes the risk network structure of persons with HIV infection during its early epidemic phase in Colorado Springs, USA, using analysis of community-wide HIV/AIDS contact tracing records (sexual and injecting drug partners) from 1985 to 1999. Paired partner information from other...

  • The AIDS Epidemic: Personal and Social Consequences.  // Annals of Internal Medicine;2/15/92, Vol. 116 Issue 4, p339 

    Editorial. Deals with the personal and social consequences of the AIDS epidemic. Background on the publication of articles on HIV infection; Range of topics discussed in articles on the disease.

  • HIV's raw aggression. Cowley, Geoffrey // Newsweek;1/23/1995, Vol. 125 Issue 4, p58 

    Cites two new studies that look at how the AIDS virus kills. Finding that HIV is not a subtle intruder that lies dormant in the cells but a rabid aggressor that battles the body from the first day of infection; Report in the journal `Nature'; Details; Why researchers should focus on crippling...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics